When asked what Moleculent’s cell-cell interaction mapping technology provides to translational researchers, CEO Olle Ericsson explained that it adds “a new layer of information,” specifically ...
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the launch of a U.S. Expanded Access Program (EAP) for up to 250 adults with post-bariatric hypoglycemia (PBH) ...
MedPage Today on MSN
FDA opens early access to novel pancreatic cancer drug generating buzz
Requests for treatment with daraxonrasib must come from licensed U.S. physicians ...
Sujal Patel, Co-Founder and CEO, highlighted the public unveiling of the Nautilus Voyager instrument at the US Human Proteome Organization Conference, calling it a "key highlight" and noting, "The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results